Vascular Malformations: all 79 studies
Page 1 of 1. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.
- Fetal Embolization for Severe Vein of Galen Malformation - A Feasibility and Safety TrialNot yet recruitingNCT07927725Not applicable
- A Study of Clinical Practice and Real-world Care of Patients Treated With mTOR, PI3K, and MEK Inhibitors for Extracranial Vascular AnomaliesNot yet recruitingNCT07767877
- Bleomycin Electrosclerotherapy (BEST) for Slow-flow Vascular MalformationsEnrolling by invitationNCT07720570
- Topical TOR-582 Treatment of Epistaxis in HHTNot yet recruitingNCT07667413Phase 1
- Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)RecruitingNCT07601425Phase 1/2
- Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)RecruitingNCT07579962Phase 2
- 24VA021; VATCH Trametinib for Ras/MAPK Pathway VAsRecruitingNCT07549646Phase 2
- 24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAsRecruitingNCT07543822Phase 2
- A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular AnomaliesNot yet recruitingNCT07477548Phase 2
- Microwave Ablation for Treatment of Vascular Malformations: Efficacy and SafetyNot yet recruitingNCT07404670Not applicable
- An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular MalformationsRecruitingNCT07037238Phase 2
- Diagnostic Imaging of Vascular Malformations Using MSOT and ULMNot yet recruitingNCT06994260
- Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)RecruitingNCT06975618Phase 1/2
- Radiofrequency Ablation of Vascular AnomaliesNot yet recruitingNCT06803667Not applicable
- A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)RecruitingNCT06789913Phase 2
- A Study of Enalapril in Treatment of Venous MalformationsRecruitingNCT06788314Phase 2
- Institutional Registry of Rare DiseasesRecruitingNCT06573723
- Investigation of Lipedema, Lymphedema and Vascular Malformations by Multispectral Optoacoustic Tomography (MSOT)Enrolling by invitationNCT06399367
- Comprehensive HHT Outcomes Registry of the United States (CHORUS)RecruitingNCT06259292
- Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational StudyRecruitingNCT06189092
- Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular MalformationsRecruitingNCT06160739
- International Registry of Congenital Portosystemic Shunt (IRCPSS)Enrolling by invitationNCT06041906
- A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular MalformationsRecruitingNCT05983159Phase 2
- Aneurysm Genetic Risk in Patients With QIB ChangesRecruitingNCT05317169
- A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac DiseaseRecruitingNCT04464655
- Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 StudyRecruitingNCT04194619
- Patient Reported Outcomes for Vascular Malformations EmbolizatioN (PROVEN)RecruitingNCT04104464
- Identification of Biomarkers for Patients with Vascular AnomaliesRecruitingNCT03001180
- Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard CareRecruitingNCT02638389Phase 3
- Lymphatic Anomalies Registry for the Assessment of Outcome DataRecruitingNCT02399527
- Treatment of Brain AVMs (TOBAS) StudyRecruitingNCT02098252Not applicable
- International Lymphatic Disease and Lymphedema RegistryRecruitingNCT01336790
- Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic DisordersEnrolling by invitationNCT00833599
- Influence of Flat-knitted Compression Stockings Class I and II on Venous MalformationsCompletedNCT04637997Not applicableResults posted
- A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular TumorsTerminatedNCT02110069Phase 2Results posted
- Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of ConceptCompletedNCT01752049Phase 1/2Results posted
- A Study to Evaluate Sildenafil for the Treatment of Lymphatic MalformationsCompletedNCT01290484Phase 1/2Results posted
- Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular MalformationCompletedNCT00964496Phase 2Results posted
- Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine StainsCompletedNCT00556946Not applicableResults posted
- Intralesional Bleomycin Sclerotherapy for Low-Flow Vascular Malformations of the Head and NeckCompletedNCT07728825Phase 4
- Comparative Study Between Sclerosing Agents Used in Treatment of Vascular MalformationCompletedNCT07320430Not applicable
- Trametinib Treatment for Complicated Vascular AnomaliesActive, not recruitingNCT07072403Phase 1/2
- Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter StudyCompletedNCT06986954
- Safety and Efficacy Of Amber Peripheral Liquid Embolic SystemActive, not recruitingNCT06456125Not applicable
- SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsActive, not recruitingNCT06239480Phase 3
- National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)CompletedNCT05563831
- Bleomycin Electrosclerotherapy Treatment of Vascular Malformations: A Feasibility StudyStatus unknownNCT05494710Not applicable
- SelfWrap-Assisted Arteriovenous FistulasActive, not recruitingNCT05418816Not applicable
- Radifocus (Terumo) Versus Silverway (Asahi) to Deliver Catheters During Cardiac CatheterizationCompletedNCT05231889Not applicable
- The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous MalformationsStatus unknownNCT05113420
- A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular PathologyCompletedNCT04999618Phase 4
- Vascular Anomaly Pathology and Genomics Biopsy StudyCompletedNCT04836884Not applicable
- Efficacy and Safety of Rapamycin to Complex Vascular Anomalies in Pediatric PatientsStatus unknownNCT04598204Phase 2/3
- MiDura-Study (Neuro-Patch in Duraplasty)CompletedNCT04189172
- Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible LesionsTerminatedNCT04172922Phase 1
- Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of LifeStatus unknownNCT03987152Phase 3
- Topical Sirolimus in Cutaneous Lymphatic MalformationsCompletedNCT03972592Phase 2
- Transvenous Approach for the Treatment of Cerebral Arteriovenous MalformationsCompletedNCT03691870Not applicable
- Efficacy and Safety of Sirolimus to Vascular AnomaliesCompletedNCT03583307Not applicable
- Development of a Specific Scale of Life'Quality for Children With Low-flow Vascular MalformationsStatus unknownNCT03440827Not applicable
- Bioseal Dural Sealing Study BIOS-14-001CompletedNCT03110783Phase 3
- Stereotactic MRI Based Image Guidance for the Treatment of Vascular Malformations - a Pilot StudyCompletedNCT02991352Not applicable
- Electrosclerotherapy for Capillary MalformationsStatus unknownNCT02883023Phase 2
- Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related BleedingWithdrawnNCT02754960Phase 2
- the Efficiency of Endoscopic Treatment for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular MalformationStatus unknownNCT02716545Not applicable
- the Efficiency of Thalidomide for Recurrent Small Intestinal Bleeding Due to Gastrointestinal Vascular MalformationCompletedNCT02707484Phase 3
- Bone Health in Patients With OvergrowthCompletedNCT02561182
- suPERficial Slow-flow Vascular malFORMations Treated With sirolimUSCompletedNCT02509468Phase 2
- Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to AngiodysplasiasCompletedNCT02384122Phase 3
- Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course TreatmentWithdrawnNCT02301949Phase 2
- AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)TerminatedNCT02250456
- Characterization of the Pathogenesis of Primary and Secondary Lymphatic DisordersTerminatedNCT02156115
- The Management of Postoperative Craniotomy Pain in Pediatric PatientsCompletedNCT01576601
- Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)WithdrawnNCT01408056Phase 2
- Vascular Malformations and Abnormalities of GrowthCompletedNCT01105676Not applicable
- Diagnosis of Hemangiomas and Vascular MalformationsCompletedNCT00577213
- Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm WavelengthsCompletedNCT00573729Phase 1
- Genetic Basis of HemangiomasTerminatedNCT00466375
- Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.CompletedNCT00261391Phase 1